Smruthi Organics Limited (BOM:540686)
India flag India · Delayed Price · Currency is INR
131.50
+3.10 (2.41%)
At close: Jul 30, 2025

Smruthi Organics Company Description

Smruthi Organics Limited manufactures and markets active pharmaceutical ingredient (API) products to India.

The company provides API for cardiovascular that includes amlodipine besilate, losartan potassium, telmisartan, s - amlodipine besilate, s - amlodipine malelate, and valsartan; for anti diabetic, which comprises metformin HCL, vildagliptin, teneligliptin, and dapagliflozin; and for anti infectives that consists of ciprofloxacin HCL, diloxanide furoate, norfloxacin, and pefloxacin mesylate, as well as ticagrelor for anti platelets.

It also offers drug intermediates, such as amlodipine base, s-amlodipine base, and phthaloyl amlodipine.

In addition, the company is developing empagliflozin for anti-diabetics; and apixaban and rivaroxaban for anti-platelets.

It also exports its products. The company was incorporated in 1989 and is headquartered in Solapur, India.

Smruthi Organics Limited
CountryIndia
Founded1989
IndustryMedicinal Chemicals and Botanical Products
Employees267
CEOPurushotham Eaga

Contact Details

Address:
165-A, Balaji Bhavan
Solapur, Maharashtra 413001
India
Phone91 21 7231 0267
Websitesmruthiorganics.com

Stock Details

Ticker Symbol540686
ExchangeBombay Stock Exchange
Fiscal YearApril - March
Reporting CurrencyINR
SIC Code2833

Key Executives

NamePosition
Purushotham EagaChief Executive Officer
Swapnil EagaChief Financial Officer